Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
about
Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusionLeukoreduction for the prevention of adverse reactions from allogeneic blood transfusionInsights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the USLeucoreduction of blood components: an effective way to increase blood safety?Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibilityClinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery.Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in Japan.Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactionsRole of Leukoreduction of Packed Red Blood Cell Units in Trauma Patients: A ReviewLeukoreduced blood components: Advantages and strategies for its implementation in developing countries.Platelet transfusion therapy in sub-Saharan Africa: bacterial contamination, recipient characteristics, and acute transfusion reactions.Estimation of the prevalence and rate of acute transfusion reactions occurring in Windhoek, Namibia.Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.Utilization management in the blood transfusion serviceAcetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactionsPremedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions.Allogeneic versus autologous blood transfusion and survival after radical prostatectomy.Transfusion premedications: a growing practice not based on evidence.Red Blood Cell Transfusions Impact Pneumonia Rates After Coronary Artery Bypass Grafting.Scratching the surface of allergic transfusion reactions.The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.Duration of red blood cell storage and inflammatory marker generationRed blood cell transfusions for thalassemia: results of a survey assessing current practice and proposal of evidence-based guidelines.Effects of Leukoreduction and Premedication With Acetaminophen and Diphenhydramine in Minimizing Febrile Nonhemolytic Transfusion Reactions and Allergic Transfusion Reactions During and After Blood Product Administration: A Literature Review With ReRed blood cell storage lesion.Red cell transfusion and the immune system.Molecular mechanisms of erythrocyte aging.Effects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.Storage characteristics of multiple-donor pooled red blood cells compared to single-donor red blood cell units.Transfusion premedication practices among pediatric health care practitioners in Canada: results of a national survey.Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.Retrospective evaluation of the effect of red blood cell product age on occurrence of acute transfusion-related complications in dogs: 210 cases (2010-2012).Feeling the burn: the significant burden of febrile nonhemolytic transfusion reactions.Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.Estimation of the infectious viral load required for transfusion-transmitted human T-lymphotropic virus type 1 infection (TT-HTLV-1) and of the effectiveness of leukocyte reduction in preventing TT-HTLV-1.
P2860
Q24187243-BBB2F97E-CD1B-4A8C-AEA1-5544D9B79CA2Q24201602-7161FB64-F453-484A-8559-2391B675965DQ24288772-6B9BB1BB-6D6C-4C53-9DDF-A39AFC1559A5Q26771857-41A81E17-6BAC-45BB-B492-9B4753D76C7FQ26784256-A7272D98-933A-4BF3-8F19-DCC3207754CEQ33236246-2220F8E9-8785-4605-B1FC-8D006EC43382Q33408363-EC0256C7-DE2C-4BBA-8CDA-9FF0A59484F8Q33690883-82069A3D-BD9F-48A5-98B5-12695C20BE30Q33707808-1F9CE070-8DCC-4E20-83F9-A5D9AE2B7428Q33760699-2EE81F77-90B3-451B-B3A3-C64963A5805DQ33920013-C9C2AE5C-E606-4256-A696-19EFB7C74EACQ33953448-4D1A4F73-8425-4A2B-BE7D-9B7E05F8DF24Q33953454-FDC775BC-9884-45F3-A130-14231AE68E53Q35492937-7ACE400B-6415-45D6-ACBC-1BA5EF303BBAQ35792449-3A79EED2-6851-4707-A3B8-B8854C0DD10EQ35922810-8C88EBBA-C4F6-4E81-9AD1-6882F2E8CD47Q36092285-EE79AB3B-32C4-4E51-8F79-114CF4665261Q36237664-4D8B78D1-F83F-4B66-8456-652FDC4B7F88Q36428284-57319072-452F-46D4-92CF-6DCA77DC6BCCQ36663533-A16750BB-5C0A-4F59-9436-149D02E20EDCQ36831189-0FBB904F-ADBD-4A87-80B2-BFA1DCBEDDA3Q36996206-D1403DAF-7099-4FBB-B50D-7C1A17872722Q37012102-A30FC416-3D29-4781-B20A-9D11349E670EQ37059214-8AA88EBC-7EE8-401C-BFA3-3EE307D4A6BBQ37679824-B4F4A134-8568-4908-9AA8-0011DA99DC05Q38194595-82D2CDE1-BF71-406C-B312-C4EBD48B130AQ38209256-27A8A66A-2D6D-429E-8EFB-2485896EFF86Q38271912-0B3518EE-9684-43C4-979B-DD6ACB9E73CFQ38273784-996C6E6F-ED9A-4622-8E59-356F39A7B39CQ38388853-46CBDD61-1F04-4A1C-89F5-BA742DD9C66AQ38534070-D7B3D6A4-96C7-4066-B735-A6C1320C0380Q38814729-696ECE94-01EC-45D4-8550-578B10DC0CA1Q38852062-BE8BD541-36F4-4D10-B0AF-B7ECF80F47B3Q39275687-264EA32A-E88B-4A2C-9EFA-8C1AA6C6A79AQ39350639-07B83BFD-6266-428E-B6E1-BCF09BD4F418Q40062728-D4D07A57-99B6-4606-A4CB-792FB1786A11Q40179540-44177232-BC1C-42D5-BD7A-2D145F17C0F3Q40186836-F9FA2C8C-70CA-497F-A235-5032173624F7Q40277127-4B016A23-6630-4C28-A29C-FB53F4C043E9Q40991139-4FC7D84D-9725-43B9-B362-6F53056C7EE4
P2860
Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Universal leukoreduction decre ...... transfusion reactions to RBCs.
@en
type
label
Universal leukoreduction decre ...... transfusion reactions to RBCs.
@en
prefLabel
Universal leukoreduction decre ...... transfusion reactions to RBCs.
@en
P2093
P2860
P1433
P1476
Universal leukoreduction decre ...... transfusion reactions to RBCs.
@en
P2093
Debra Bensen-Kennedy
Karen E King
Paul M Ness
R Sue Shirey
Sandra K Thoman
Warren S Tanz
P2860
P356
10.1046/J.0041-1132.2004.00609.X
P577
2004-01-01T00:00:00Z